Status:
RECRUITING
Modified Periosteal Inhibition with Simultaneous Implant Placement in Aesthetic Zone
Lead Sponsor:
Tanta University
Conditions:
Immediate Dental Implant
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
A randomized controlled clinical and radiographic trial. Twenty sites with remaining roots or non-restorable teeth in the maxillary anterior region that fulfill the inclusion criteria will be selected...
Detailed Description
A randomized controlled clinical and radiographic trial. The purpose of the present study will be explained to the patients and informed consents will be obtained according to guidelines adopted by th...
Eligibility Criteria
Inclusion
- Intact labial plate of bone with thickness ≤1 mm (Socket type I).
- Moderate to thick gingival phenotype.
- Bone quality ranges from D2-D3 as gained from preoperative cone beam computed tomography.
- Presence of at least 3 mm of keratinized gingiva.
- Optimal compliance as evidenced by no missing treatment appointments and positive attitude towards oral hygiene.
Exclusion
- Medically compromised patients and systemic conditions precluding implant and periodontal surgery.
- Pregnant or lactating women.
- Smoking
- Absence of buccal plate of bone.
- History of chemotherapy, radiotherapy in head and/or neck region.
- Bisphosphonate therapy.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06519773
Start Date
July 1 2024
End Date
October 1 2025
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ElGharbiya
Tanta, Egypt